NYSE$RVTY
Revvity Inc · Q4 2025 earnings
Q4 2025 earnings · · Before market open · Investor relations
Briefing
Revvity reported Q4 2025, revenue of $772M, net income of $98.4M, diluted EPS of $0.82.
For Q4 2025, Revvity reported revenue of $772M, net income of $98.4M, diluted EPS was $0.82. Management discusses segment performance, capital allocation, and outlook in the earnings filing.
- Revenue $772M.
- Net income $98.4M.
- Diluted EPS $0.82.
Headline financials
Revenue & EPS history
Revvity · Revenue · Quarterly
$772M
Revenue by segment
Revvity · $671M total across 2 segments · Q3 2023
- Diagnostics$363M—54.1%
- Life Sciences$308M—45.9%
Forward guidance
The release discusses Revvity's outlook for upcoming periods, including capital allocation, operating priorities, and market risks, without relying solely on numeric EPS bridges.
Tailwinds
- Revvity cites operational execution and demand trends supporting the outlook.
- Balance sheet and liquidity actions aim to fund growth and returns.
Headwinds
- Macro, pricing, and input-cost volatility could pressure margins.
- Segment mix and one-time items may affect quarter-to-quarter comparability.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2025
-0.1%
Avg return
Earnings day
+0.3%
Avg return
5 days after
-0.0%
Avg return
30 days after
48%
31 / 64 earnings
Positive
+10.4%
Q2 2024
Best reaction
-16.3%
Q3 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -0.5% | +17.0% | +16.7% | |
| Q4 2025 | -4.5% | -6.6% | -9.5% | |
| Q3 2025 | -1.8% | -5.4% | +5.8% | |
| Q2 2025 | +3.3% | +1.9% | -5.8% | |
| Q1 2025 | +0.8% | -0.3% | -3.1% | |
| Q4 2024 | -0.5% | -3.5% | -11.6% | |
| Q3 2024 | +4.1% | +1.2% | -4.1% | |
| Q2 2024 | +10.4% | +7.1% | +5.3% | |
| Q1 2024 | +0.9% | -0.9% | +8.1% | |
| Q4 2023 | -1.4% | -2.8% | -0.1% | |
| Q3 2023 | -16.3% | -9.9% | -8.6% | |
| Q2 2023 | +1.8% | +0.2% | -4.8% | |
| Q1 2023 | -6.6% | -8.3% | -10.8% | |
| Q4 2022 | -2.4% | -3.8% | -9.1% | |
| Q3 2022 | -2.3% | +11.0% | +9.9% | |
| Q2 2022 | +0.6% | +0.4% | -11.8% | |
| Q1 2022 | +6.2% | -0.0% | +2.0% | |
| Q4 2021 | +7.5% | +6.3% | +4.0% | |
| Q3 2021 | -1.3% | -4.3% | +2.1% | |
| Q2 2021 | +3.5% | +10.9% | +12.6% | |
| Q1 2021 | +4.6% | +8.0% | +6.2% | |
| Q4 2020 | -8.0% | -4.5% | -18.2% | |
| Q3 2020 | +1.3% | +4.4% | +1.7% | |
| Q2 2020 | +4.1% | +3.4% | -0.4% | |
| Q1 2020 | +7.2% | +6.3% | +18.4% | |
| Q4 2019 | -2.3% | -7.3% | -13.8% | |
| Q3 2019 | -2.3% | -0.4% | +5.6% | |
| Q2 2019 | -7.9% | -11.0% | -13.9% | |
| Q1 2019 | -0.5% | +1.4% | -8.6% | |
| Q4 2018 | +0.7% | +2.8% | +6.9% | |
| Q3 2018 | -4.5% | -3.1% | +1.6% | |
| Q2 2018 | +9.3% | +8.2% | +16.7% | |
| Q1 2018 | -2.2% | -1.7% | +0.4% | |
| Q4 2017 | +1.6% | -0.5% | -5.4% | |
| Q3 2017 | -2.3% | -1.6% | +1.2% | |
| Q2 2017 | -3.6% | -4.0% | +0.4% | |
| Q1 2017 | +3.3% | +4.9% | +8.8% | |
| Q4 2016 | -3.0% | -2.0% | +2.2% | |
| Q3 2016 | -2.1% | -1.9% | +2.3% | |
| Q2 2016 | -0.1% | -0.3% | +0.5% | |
| Q1 2016 | +1.0% | — | — | |
| Q3 2015 | -2.4% | — | — | |
| Q2 2015 | +4.3% | — | — | |
| Q1 2015 | +1.5% | — | — | |
| Q4 2014 | +2.7% | — | — | |
| Q3 2014 | +1.9% | — | — | |
| Q2 2014 | -5.5% | — | — | |
| Q1 2014 | -3.4% | — | — | |
| Q4 2013 | +2.3% | — | — | |
| Q3 2013 | -1.7% | — | — | |
| Q2 2013 | +6.8% | — | — | |
| Q1 2013 | -10.6% | — | — | |
| Q4 2012 | -3.5% | — | — | |
| Q3 2012 | -1.0% | — | — | |
| Q2 2012 | +5.4% | — | — | |
| Q4 2008 | -0.5% | — | — | |
| Q1 2012 | +3.0% | — | — | |
| Q1 2011 | +0.2% | — | — | |
| Q4 2011 | +3.5% | — | — | |
| Q3 2009 | +1.4% | — | — | |
| Q3 2011 | +1.4% | — | — | |
| Q2 2009 | -3.1% | — | — | |
| Q2 2011 | -3.1% | — | — | |
| Q4 2010 | -3.1% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro